Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

Date

Lundi, 5 février 2024, Journée Entière
Jeudi, 8 février 2024, Journée Entière

Emplacement

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 Ko - PDF)

Première publication: Dernière mise à jour:
Voir

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 Ko - PDF)

Première publication:
Voir

Share this page